GWM
TMO icon

Gibbs Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Gibbs Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.51M Buy
3,074
+2,307
+301% +$1.25M 0.2% 106
2025
Q4 		$475K Sell
767
-12
-2% -$6.79K 0.11% 207
2025
Q3 		$378K Sell
779
-6,056
-89% -$2.82M 0.09% 243
2025
Q2 		$2.77M Buy
6,835
+745
+12% +$311K 0.53% 36
2025
Q1 		$3.03M Buy
6,090
+945
+18% +$512K 0.73% 26
2024
Q4 		$2.68M Buy
5,145
+861
+20% +$473K 0.73% 30
2024
Q3 		$2.65M Buy
4,284
+1,463
+52% +$866K 0.86% 26
2024
Q2 		$1.56M Buy
2,821
+1,002
+55% +$574K 0.63% 35
2024
Q1 		$1.06M Buy
+1,819
New +$1.02M 0.61% 35

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Gibbs Wealth Management's TMO Position: Q1 2026 in Review

Gibbs Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 301% in Q1 2026, buying an estimated $1.25M and bringing the position to 3,074 shares worth $1.51M. The position accounts for 0.2% of the portfolio, ranked #106.

Gibbs Wealth Management first reported a position in TMO in Q1 2024 and has held it in 9 quarters since. The position peaked at $3.03M in Q1 2025. 2,605 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Gibbs Wealth Management held 3,074 shares of Thermo Fisher Scientific worth $1.51M as of Q1 2026.
  • Gibbs Wealth Management bought 2,307 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.25M.
  • Thermo Fisher Scientific made up 0.2% of Gibbs Wealth Management's portfolio in Q1 2026, its #106 holding.
  • Gibbs Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2024 and has held it in 9 quarters since.
  • Gibbs Wealth Management's Thermo Fisher Scientific position peaked at $3.03M in Q1 2025.
  • 2,605 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Gibbs Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.